Rubraca® (rucaparib)
for Ovarian Cancer

Rubraca (rucaparib) is a cancer medication used to treat ovarian, fallopian tube, or primary peritoneal cancer in patients with an abnormal "BRCA" gene. It is also used for prostate cancer with the same genetic marker when the cancer has spread and other treatments have failed. Rubraca is a PARP inhibitor that works by blocking a protein that repairs DNA in cancer cells, causing the cells to die and the tumor to shrink.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Ovarian Cancer